These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 2741646

  • 1. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis.
    Deguchi K, Izumi K, Noguchi M, Yuwasaki E, Suzuki H, Mori Y, Deguchi A, Ohkubo I, Tsuda M, Wada H.
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):140-6. PubMed ID: 2741646
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
    Uchida Y.
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
    [Abstract] [Full Text] [Related]

  • 4. Effects of recombinant human erythropoietin (EPOCH) on the coagulation and fibrinolytic systems and platelet function in pre-dialysis patients with chronic renal failure.
    Kaizu K, Uriu K, Eto S.
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):989-97. PubMed ID: 8255011
    [Abstract] [Full Text] [Related]

  • 5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 6. Fibrinous pericarditis and fibrinolysis in chronic dialysis patients.
    Cochran M, Lawton S, Rowlands LM.
    Clin Nephrol; 1979 Jan; 11(1):23-5. PubMed ID: 428151
    [Abstract] [Full Text] [Related]

  • 7. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO.
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [Abstract] [Full Text] [Related]

  • 8. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H, Ohno M, Ohashi H.
    Adv Perit Dial; 2000 Nov; 16():152-5. PubMed ID: 11045282
    [Abstract] [Full Text] [Related]

  • 9. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA, Boisclair MD, Lane DA, Thompson E, Curtis JR.
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [Abstract] [Full Text] [Related]

  • 10. [Disorders of blood coagulation and fibrinolysis in patients with chronic renal failure during treatment with hemodialysis, and methods of correction].
    Neĭmark MI.
    Ter Arkh; 1984 Jan; 56(7):48-53. PubMed ID: 6484834
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative study of low molecular weight heparin and unfractionated heparin in patients on maintenance hemodialysis].
    Noguchi M, Izumi K, Deguchi K, Endoh T, Tsuda M, Shirakawa S.
    Rinsho Byori; 1990 Jul; Suppl 86():177-83. PubMed ID: 2172594
    [No Abstract] [Full Text] [Related]

  • 12. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
    Undas A, Kolarz M, Kopeć G, Tracz W.
    Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
    [Abstract] [Full Text] [Related]

  • 13. Enhanced coagulation-fibrinolysis in patients on regular hemodialysis treatment.
    Nakamura Y, Chida Y, Tomura S.
    Nephron; 1991 Jun; 58(2):201-4. PubMed ID: 1830934
    [Abstract] [Full Text] [Related]

  • 14. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000 Jun; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

  • 15. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
    Erdem Y, Haznedaroglu IC, Celik I, Yalcin AU, Yasavul U, Turgan C, Caglar S.
    Nephrol Dial Transplant; 1996 Jul; 11(7):1299-305. PubMed ID: 8672026
    [Abstract] [Full Text] [Related]

  • 16. Enhanced coagulation and fibrinolysis during treatment with recombinant human erythropoietin in patients undergoing chronic hemodialysis.
    Tomura S, Nakamura Y, Tachibana K, Deguchi F, Ando R, Chida Y, Marumo F.
    Blood Purif; 1993 Jul; 11(6):370-7. PubMed ID: 8043258
    [Abstract] [Full Text] [Related]

  • 17. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B, Sabovic M, Zupan IP, Ponikvar JB.
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [Abstract] [Full Text] [Related]

  • 18. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
    Tsuji K, Eguchi Y, Kodama M.
    J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
    [Abstract] [Full Text] [Related]

  • 19. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
    Vaziri ND, Gonzales EC, Wang J, Said S.
    Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of blood coagulation-fibrinolysis system in patients receiving chronic hemodialysis.
    Ishii Y, Yano S, Kanai H, Maezawa A, Tsuchida A, Wakamatsu R, Naruse T.
    Nephron; 1996 Jun; 73(3):407-12. PubMed ID: 8832598
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.